Tunch Akmandor Presents Poster A-140 on IFN-γ Microneedle Platform at EADO 2026
Tunch Akmandor/LinkedIn

Tunch Akmandor Presents Poster A-140 on IFN-γ Microneedle Platform at EADO 2026

Tunch Akmandor, Mental Health Advocate at Health Services Laboratories, shared a post on LinkedIn:

“Day 1 at EADO 2026.

Presenting Poster A-140:

IFN-γ-Loaded Dissolvable Sugar Microneedles for Local Intradermal Delivery in Cutaneous Squamous Cell Carcinoma.

In this work, we explore a dissolvable microneedle platform designed for targeted intradermal delivery of cytokines:

  • Enables localised IFN-γ administration to enhance tumour immune activation.
  • Aims to reduce systemic exposure while maintaining therapeutic effect.
  • Supports the development of precision, localised immunotherapy strategies in dermato-oncology.

This project was developed in collaboration with colleagues at Middlesex University University College London Hospitals NHS Foundation Trust and UCL, alongside Erika Loizidou, Cristina Russo, and Sue Outram .

It has been great to engage with the international dermato-oncology community and exchange perspectives on emerging directions in immunotherapy and translational drug delivery.

A pleasure also to connect with leading experts in the field, including world-famous Teresa Amaral MD, PhD.

Looking forward to the next sessions and discussions with Tolga Ersöz.”

Tunch Akmandor

Other articles featuring Tunch Akmandor on OncoDaily.